BR112017014978A2 - método in vitro de diagnóstico da atividade de doença de crohn e kit - Google Patents
método in vitro de diagnóstico da atividade de doença de crohn e kitInfo
- Publication number
- BR112017014978A2 BR112017014978A2 BR112017014978A BR112017014978A BR112017014978A2 BR 112017014978 A2 BR112017014978 A2 BR 112017014978A2 BR 112017014978 A BR112017014978 A BR 112017014978A BR 112017014978 A BR112017014978 A BR 112017014978A BR 112017014978 A2 BR112017014978 A2 BR 112017014978A2
- Authority
- BR
- Brazil
- Prior art keywords
- crohn
- vitro method
- disease
- diagnosing
- kit
- Prior art date
Links
- 208000011231 Crohn disease Diseases 0.000 title abstract 5
- 238000000338 in vitro Methods 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 230000009266 disease activity Effects 0.000 title 1
- 239000012472 biological sample Substances 0.000 abstract 2
- 239000000523 sample Substances 0.000 abstract 2
- 238000003745 diagnosis Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15305142 | 2015-01-30 | ||
| PCT/EP2016/051989 WO2016120475A1 (en) | 2015-01-30 | 2016-01-29 | Host dna as a biomarker of crohn's disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112017014978A2 true BR112017014978A2 (pt) | 2018-03-20 |
Family
ID=52577797
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112017014978A BR112017014978A2 (pt) | 2015-01-30 | 2016-01-29 | método in vitro de diagnóstico da atividade de doença de crohn e kit |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US9873914B2 (enExample) |
| EP (1) | EP3250710B1 (enExample) |
| JP (1) | JP6585175B2 (enExample) |
| CN (1) | CN107208159A (enExample) |
| AU (1) | AU2016211113A1 (enExample) |
| BR (1) | BR112017014978A2 (enExample) |
| CA (1) | CA2973307A1 (enExample) |
| ES (1) | ES2693973T3 (enExample) |
| IL (1) | IL253327B (enExample) |
| MX (1) | MX376501B (enExample) |
| PL (1) | PL3250710T3 (enExample) |
| WO (1) | WO2016120475A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3250710B1 (en) * | 2015-01-30 | 2018-08-22 | Enterome | Host dna as a biomarker of crohn's disease |
| CA3058943C (en) | 2017-04-03 | 2023-10-17 | Gusto Global, Llc | Rational design of microbial-based biotherapeutics |
| SG11202007686VA (en) | 2018-02-12 | 2020-09-29 | 10X Genomics Inc | Methods characterizing multiple analytes from individual cells or cell populations |
| CN108220286A (zh) * | 2018-03-28 | 2018-06-29 | 上海锐翌生物科技有限公司 | 粪便宿主dna甲基化检测方法 |
| CN114882944B (zh) * | 2022-06-22 | 2024-09-20 | 深圳微伴医学检验实验室 | 基于Metagenome测序的肠道微生物样品宿主性别鉴定方法、装置及应用 |
| EP4495262A1 (en) | 2023-07-21 | 2025-01-22 | Luxia Scientific | Host dna as a biomarker of vaginal health |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6586177B1 (en) | 1999-09-08 | 2003-07-01 | Exact Sciences Corporation | Methods for disease detection |
| US20040259101A1 (en) | 2003-06-20 | 2004-12-23 | Shuber Anthony P. | Methods for disease screening |
| CN101238224A (zh) * | 2005-06-06 | 2008-08-06 | 惠氏公司 | 炎性肠病的外周血单核细胞的表达谱 |
| RU2313576C1 (ru) * | 2006-05-29 | 2007-12-27 | Ростовский-на-Дону научно-исследовательский противочумный институт Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека | РЕКОМБИНАНТНАЯ ПЛАЗМИДА, ЭКСПРЕССИРУЮЩАЯ КЛОНИРОВАННЫЙ ГЕН Ace VIBRIO CHOLERAE И ШТАММ ESCHERICHIA COLI-ПРОДУЦЕНТ ACCESSORY CHOLERAE ENTEROTOXIN VIBRIO CHOLERAE |
| EP2097540A4 (en) * | 2006-11-17 | 2010-09-01 | Genizon Biosciences Inc | GENETIC CARD OF HUMAN GENES ASSOCIATED WITH CROHN'S DISEASE |
| WO2009065551A1 (en) * | 2007-11-20 | 2009-05-28 | Roche Diagnostics Gmbh | Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex |
| EP2377883A1 (en) * | 2010-04-15 | 2011-10-19 | Universite d'Auvergne Clermont I | Antagonists for the prevention or treatment of inflammatory bowel disease, and more particularly of Crohn's disease |
| GB201107466D0 (en) * | 2011-05-05 | 2011-06-15 | Loktionov Alexandre | Device and method for non-invasive collection of colorectal mucocellular layer and disease detection |
| EP2721173A1 (en) * | 2011-06-14 | 2014-04-23 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for determining the expression level of a gene of interest including correction of rt-qpcr data for genomic dna-derived signals |
| CN103911440B (zh) * | 2014-03-13 | 2015-04-22 | 南京医科大学 | 一种与铂类化疗药物肝脏毒性相关的snp标志物及其应用 |
| EP3250710B1 (en) * | 2015-01-30 | 2018-08-22 | Enterome | Host dna as a biomarker of crohn's disease |
-
2016
- 2016-01-29 EP EP16702120.3A patent/EP3250710B1/en active Active
- 2016-01-29 JP JP2017540126A patent/JP6585175B2/ja not_active Expired - Fee Related
- 2016-01-29 US US15/011,314 patent/US9873914B2/en active Active
- 2016-01-29 BR BR112017014978A patent/BR112017014978A2/pt not_active IP Right Cessation
- 2016-01-29 CA CA2973307A patent/CA2973307A1/en not_active Abandoned
- 2016-01-29 WO PCT/EP2016/051989 patent/WO2016120475A1/en not_active Ceased
- 2016-01-29 AU AU2016211113A patent/AU2016211113A1/en not_active Abandoned
- 2016-01-29 PL PL16702120T patent/PL3250710T3/pl unknown
- 2016-01-29 MX MX2017009752A patent/MX376501B/es active IP Right Grant
- 2016-01-29 ES ES16702120.3T patent/ES2693973T3/es active Active
- 2016-01-29 CN CN201680007943.4A patent/CN107208159A/zh active Pending
-
2017
- 2017-07-05 IL IL253327A patent/IL253327B/en active IP Right Grant
-
2018
- 2018-01-22 US US15/877,336 patent/US10793911B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP6585175B2 (ja) | 2019-10-02 |
| PL3250710T3 (pl) | 2019-02-28 |
| CA2973307A1 (en) | 2016-08-04 |
| US20160258017A1 (en) | 2016-09-08 |
| EP3250710B1 (en) | 2018-08-22 |
| ES2693973T3 (es) | 2018-12-17 |
| MX376501B (es) | 2025-03-07 |
| AU2016211113A1 (en) | 2017-09-07 |
| US20180251844A1 (en) | 2018-09-06 |
| WO2016120475A1 (en) | 2016-08-04 |
| IL253327B (en) | 2020-06-30 |
| IL253327A0 (en) | 2017-09-28 |
| CN107208159A (zh) | 2017-09-26 |
| US9873914B2 (en) | 2018-01-23 |
| MX2017009752A (es) | 2017-12-07 |
| US10793911B2 (en) | 2020-10-06 |
| EP3250710A1 (en) | 2017-12-06 |
| JP2018504909A (ja) | 2018-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112017014978A2 (pt) | método in vitro de diagnóstico da atividade de doença de crohn e kit | |
| TWD201299S (zh) | 滑動影像系統 | |
| BR112013014662A2 (pt) | sistema de imagem por ultrassonografia, método para adquirir imagens de ultrassonografia e programa de computador | |
| BR112017004379A2 (pt) | determinação de vivacidade em multi-estágio | |
| BR112014018970A8 (pt) | Dispositivos de coleta de amostra com agentes de estabilização sanguínea | |
| BR112015030179A2 (pt) | sistema e método de apoio para cuidados com a saúde para determinar o tratamento de um paciente; e programa de computador | |
| BR112014003834A2 (pt) | sistema e método de administração de dados, processador para uso em um sistema de administração de dados e programa de computador | |
| BR112013018686A2 (pt) | sistemas e métodos para uso médico de captura e imageamento de movimentação | |
| BR112018070971A2 (pt) | métodos e kits para a diagnose e estratificação de risco de pacientes com isquemia | |
| BR112015029875A2 (pt) | sistemas e métodos para diagnóstico de depressão e outras condições médicas | |
| CL2018001343A1 (es) | Lactoferrina para uso en el diagnóstico o el pronóstico de la enfermedad de alzheimer o en el diagnóstico de la enfermedad de parkinson | |
| BR112013031431A2 (pt) | método para o diagnóstico da doença de gaucher | |
| BR112017022320A2 (pt) | métodos para tratamento de câncer de pulmão | |
| WO2016201365A3 (en) | Methods for treating cancers | |
| BR112015027249A2 (pt) | método de diagnóstico de câncer | |
| EA201500526A1 (ru) | Композиции и методы лечения воспалительных заболеваний инфекционного и неинфекционного происхождения | |
| BR112017027304A2 (pt) | método para o diagnóstico de doença de farber | |
| BR112018005894A2 (pt) | sistema e método de monitoramento de um paciente com uma condição específica | |
| BR112017023343A2 (pt) | predição do risco de desenvolver uma infecção disseminada para os pacientes admitidos em uma unidade de terapia intensiva | |
| BR112015018964A2 (pt) | método para determinar se um paciente se classifica como apresentando pré-lupus e sistema para determinar se um paciente se classifica como apresentando pré-lupus | |
| BR112014033124A2 (pt) | isoformas da tropomiosina relacionadas à doença de alzheimer e a um déficit cognitivo leve | |
| 김도형 et al. | Severe periodontitis with tooth loss as a modifiable risk factor for the development of Alzheimer, vascular, and mixed dementia: National Health Insurance Service-National Health Screening Retrospective Cohort 2002? 2015 | |
| Datta et al. | Diagnostic application of conventional and newer bone marrow examination techniques in fever of unknown origin | |
| Al-Musawy et al. | Numerical Taxonomy of Micrococcaceae | |
| UA117448U (uk) | Спосіб діагностики та диференційної діагностики пневмоній періоду новонародженості |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2707 DE 22/11/2022. |